Certain Shares of Formycon AG are subject to a Lock-Up Agreement Ending on 2-AUG-2023.
Details:
Following the private placement, Formycon will be subject to a lock-up obligation with market-standard exemptions for a period of six months.
Market Closed -
Other stock markets
|
After market 03:07:54 pm | |||
48.7 EUR | +0.41% | 48.72 | +0.05% |
Apr. 25 | Formycon AG Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 18 | Formycon, Fresenius Kabi Sign Settlement Deal with Johnson & Johnson for Ustekinumab Biosimilar | MT |
1st Jan change | Capi. | |
---|---|---|
-13.65% | 919M | |
+48.02% | 56.87B | |
+37.15% | 39.72B | |
-5.67% | 39.27B | |
-6.90% | 28.73B | |
+13.30% | 26.21B | |
-15.97% | 19.79B | |
+31.64% | 12.28B | |
+28.23% | 12.23B | |
+0.35% | 12.12B |